www.fdanews.com/articles/134124-optimer-pockets-68-million-from-astellas-for-rights-to-antibiotic-in-europe
Optimer Pockets $68 Million From Astellas for Rights to Antibiotic in Europe
February 8, 2011
San Diego-based Optimer Pharmaceuticals has found a partner to help market its most important drug candidate outside the U.S.
Xconomy
Xconomy